Lymphocytic infiltration leads to degradation of lacrimal gland extracellular matrix structures in NOD mice exhibiting a Sjögren's syndrome-like exocrinopathy

Experimental Eye Research

Volumn 90, Issue 2, 2010, Pages 223-237

  Schenke Layland, Katja ^a   Xie, Jiansong ^b   Magnusson, Mattias ^c   Angelis, Ekaterini ^a   Li, Xiaodong ^b   Wu, Kaijin ^b   Reinhardt, Dieter P ^d   MacLellan, W Robb ^a   Hamm Alvarez, Sarah F ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

Collagen; Elastin; Extracellular matrix; Lacrimal gland; Matrix metalloproteinases; Sj gren's syndrome

Indexed keywords

CATHEPSIN H; COLLAGEN TYPE 1; COLLAGEN TYPE 1 ALPHA 1; COLLAGEN TYPE 1 ALPHA 2; COLLAGEN TYPE 3; COLLAGEN TYPE 3 ALPHA 1; COLLAGEN TYPE 4; COLLAGEN TYPE 4 ALPHA 1; COLLAGENASE 3; ELASTIN; FIBRONECTIN; FIBULIN 5; GELATINASE A; GELATINASE B; GLYCOSAMINOGLYCAN; HEPARAN SULFATE; LAMININ 1; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 16; PROTEINASE; SCLEROPROTEIN; TENASCIN; UNCLASSIFIED DRUG; VERSICAN;

ACINAR CELL; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; CELL COMMUNICATION; CELL INFILTRATION; CELL STRUCTURE; CONGENIC STRAIN; CONTROLLED STUDY; DEGRADATION; DOWN REGULATION; EXTRACELLULAR MATRIX; FLOW CYTOMETRY; GENE EXPRESSION; IMMUNOCOMPETENT CELL; IMMUNOREACTIVITY; INFLAMMATORY CELL; LACRIMAL GLAND; LYMPHOCYTIC INFILTRATION; LYMPHOID TISSUE; MALE; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCID MOUSE; SJOEGREN SYNDROME; UPREGULATION;

ANIMALS; BLOTTING, WESTERN; CATHEPSIN H; CELL MOVEMENT; DOWN-REGULATION; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; LACRIMAL APPARATUS; LYMPHOCYTES; MALE; MATRIX METALLOPROTEINASES; MICE; MICE, INBRED BALB C; MICE, INBRED NOD; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SJOGREN'S SYNDROME;

EID: 77649182698     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2009.10.008     Document Type: Article

References (44)

1. Andersson S.V., Hamm-Alvarez S.F., Gierow J.P. Integrin adhesion in regulation of lacrimal gland acinar cell secretion. Exp. Eye Res. 2006, 83(3):543-553.
2. Barabino S., Dana M.R. Animal models of dry eye: a critical assessment of opportunities and limitations. Invest. Ophthalmol. Vis. Sci. 2004, 45(6):1641-1646.
3. van Blokland S.C., Van Helden-Meeuwsen C.G., Wierenga-Wolf A.F., Tielemans D., Drexhage H.A., Van De Merwe J.P., Homo-Delarche F., Versnel M.A. Apoptosis and apoptosis-related molecules in the submandibular gland of the nonobese diabetic mouse model for Sjogren's syndrome: limited role for apoptosis in the development of sialoadenitis. Lab. Invest. 2003, 83(1):3-11.
4. van Blokland S.C., Versnel M.A. Pathogenesis of Sjogren's syndrome: characteristics of different mouse models for autoimmune exocrinopathy. Clin. Immunol. 2002, 103(2):111-124.
5. Cauwe B., van den Steen P.E., Opdenakker G. The biochemical, biological, and pathological kaleidoscope of cell surface substrates processed by matrix metalloproteinases. Crit. Rev. Biochem. Mol. Biol. 2007, 42(3):113-185.
6. Chen L., Glass J.D., Walton S.C., Laurie G.W. Role of laminin-1, collagen IV, and an autocrine factor(s) in regulated secretion by lacrimal acinar cells. Am. J. Physiol. 1998, 275(1 Pt1):C278-C284.
7. da Costa S.R., Wu K., Pidgeon M., Ding C., Schechter J.E., Hamm-Alvarez S.F. Male NOD mouse external lacrimal glands exhibit profound changes in the exocytotic pathway early in postnatal development. Exp. Eye Res. 2006, 82:33-45.
8. de la Cuadra-Blanco C., Peces-Peña M.D., Jáñez-Escalada L., Mérida-Velasco J.R. Morphogenesis of the human excretory lacrimal system. J. Anat. 2006, 209(2):127-135.
9. El-Hallous E., Sasaki T., Hubmacher D., Getie M., Tiedemann K., Brinckmann J., Bätge B., Davis E.C., Reinhardt D.P. Fibrillin-1 interactions with fibulins depend on the first hybrid domain and provide an adaptor function to tropoelastin. J. Biol. Chem. 2007, 282(12):8935-8946.
10. Fox R.I., Adamson T.C., Fong S., Robinson C.A., Morgan E.L., Robb J.A., Howell F.V. Lymphocyte phenotype and function of pseudolymphoma associated with Sjögren's syndrome. J. Clin. Invest. 1983, 72:52-59.
11. Fox R.I., Robinson C.A., Curd J., Kozin F., Howell F.V. Sjögren's syndrome: proposed criteria for classification. Arthritis Rheum. 1986, 29:577-585.
12. Garcia-Carrasco M., Fuentes-Alexandro S., Escarcega R.O., Salgado G., Riebeling C., Cervera R. Pathophysiology of Sjögren's syndrome. Arch. Med. Res. 2006, 37:921-932.
13. Goetzl E.J., Banda M.J., Leppert D. Matrix metalloproteinases in immunity. J. Immunol. 1996, 156:1-4.
14. Goicovich E., Molina C., Perez P., Aguilera S., Fernandez J., Olea N., Alliende C., Leyton C., Romo R., Leyton L., Gonzalez M.J. Enhanced degradation of proteins of the basal lamina and stroma by matrix metalloproteinases from the salivary glands of Sjogren's syndrome patients: correlation with reduced structural integrity of acini and ducts. Arthritis Rheum. 2004, 48(9):2574-2584.
15. Guo Z., Azzarolo A.M., Schechter J.E., Warren D.W., Wood R.L., Mircheff A.K., Kaslow H.R. Lacrimal gland epithelial cells stimulate proliferation in autologous lymphocyte preparations. Exp. Eye Res. 2000, 71:11-22.
16. Humphreys-Beher M.G., Peck A.B. New concepts for the development of autoimmune exocrinopathy derived from studies with the NOD mouse model. Arch. Oral Biol. 1999, 44(Suppl. 1):S21-S25.
17. Humphries J.D., Parry E.J., Watson R.E., Garrod D.R., Griffiths C.E. All-trans retinoic acid compromises desmosome expression in human epidermis. Br. J. Dermatol. 1998, 139(4):577-584.
18. Kim H.E., Dalal S.S., Young E., Legato M.J., Weisfeldt M.L., D'Armiento J. Disruption of the myocardial extracellular matrix leads to cardiac dysfunction. J. Clin. Invest. 2000, 106(7):857-866.
19. Kong L., Robinson C.P., Peck A.B., Vela-Roch N., Sakata K.M., Dang H., Talal N., Humphreys-Beher M.G. Inappropriate apoptosis of salivary and lacrimal gland epithelium of immunodeficient NOD-scid mice. Clin. Exp. Rheumatol. 1998, 16(6):675-681.
20. Laurie G.W., Glass J.D., Ogle R.A., Stone C.M., Sluss J.R., Chen L. " BM180": a novel basement membrane protein with a role in stimulus-secretion coupling by lacrimal acinar cells. Am. J. Physiol. 1996, 270(6 Pt1):C1743-C1750.
21. Leppert D., Lindberg R.L.P., Kappos L., Leib S.L. Matrix metalloproteinases: multifunctional effectors of inflammation in multiple sclerosis and bacterial meningitis. Brain Res. Rev. 2001, 36(2-3):249-257.
22. Lin G., Tiedemann K., Vollbrandt T., Peters H., Bätge B., Brinckmann J., Reinhardt D.P. Homo- and heterotypic fibrillin-1 and -2 interactions constitute the basis for the assembly of microfibrils. J. Biol. Chem. 2002, 277:50795-50804.
23. Marchelletta R.R., Jacobs D.T., Schechter J.E., Cheney R.E., Hamm-Alvarez S.F. The class V Myosin Motor, Myosin 5c, localizes to mature secretory vesicles and facilitates exocytosis in lacrimal Acini. Am. J. Physiol. Cell Physiol. 2008, 295:C13-C18.
24. Matsumoto I., Tsubota K., Satake Y., Kita Y., Matsumura R., Murata H., Namekawa T., Nishioka K., Iwamoto I., Saitoh Y., Sumida T. Common T cell receptor clonotype in lacrimal glands and labial salivary glands from patients with Sjögren's syndrome. J. Clin. Invest. 1996, 97(8):1969-1977.
25. Molina C., Alliende C., Aguilera S., Kwon Y.J., Leyton L., Martinez B., Leyton C., Perez P., Gonzalez M.J. Basal lamina disorganization of the acini and ducts of labial salivary glands from patients with Sjögren's syndrome: association with mononuclear cell infiltration. Ann. Rheum. Dis. 2006, 65:178-183.
26. Noursadeghi M., Tsang J., Haustein T., Miller R.F., Chain B.M., Katz D.R. Quantitative imaging assay for NF-kappaB nuclear translocation in primary human macrophages. J. Immunol. Methods 2008, 329(1-2):194-200.
27. Patel V.N., Rebustini I.T., Hoffman M.P. Salivary gland branching morphogenesis. Differentiation 2006, 74(7):349-364.
28. Perez P., Goicovich E., Alliende C., Aguilera S., Leyton C., Molina C., Pinto R., Romo R., Martinez B., Gonzalez M.J. Differential expression of matrix metalloproteinases in labial salivary glands of patients with primary Sjogren's symdrome. Arthritis Rheum. 2000, 43(12):2807-2817.
29. Pérez-Rivero G., Ruiz-Torres M.P., Díez-Marqués M.L., Canela A., López-Novoa J.M., Rodríguez-Puyol M., Blasco M.A., Rodríguez-Puyol D. Telomerase deficiency promotes oxidative stress by reducing catalase activity. Free Radic. Biol. Med. 2008, 45(9):1243-1251.
30. Pillemer S.R., Matteson E.L., Jacobsson L.T., Martens P.B., Melton L.J., O'Fallon W.M., Fox P.C. Incidence of physician-diagnosed primary Sjogren syndrome in residents of Olmsted County, Minnesota. Mayo Clin. Proc. 2001, 76:593-599.
31. Robinson C.P., Yamachika S., Alford C.E., Cooper C., Pichardo E.L., Shah N., Peck A.B., Humphreys-Beher M.G. Elevated levels of cysteine protease activity in saliva and salivary glands of the nonobese diabetic (NOD) mouse model for Sjögren syndrome. Proc. Natl. Acad. Sci. USA 1997, 94:5767-5771.
32. Saegusa K., Ishimaru N., Yanagi K., Arakaki R., Ogawa K., Saito I., Katunuma N., Hayashi Y. Cathepsin S inhibitor prevents autoantigen presentation and autoimmunity. J. Clin. Invest. 2002, 110(3):361-369.
33. Schenke-Layland K. Non-invasive multiphoton imaging of extracellular matrix structures. J. Biophoton 2008, 6:451-462.
34. Schenke-Layland K., Riemann I., Opitz F., König K., Halbhuber K.J., Stock U.A. Comparative study of cellular and extracellular matrix composition of native and tissue engineered heart valves. Matrix Biol. 2004, 23:113-125.
35. Schenke-Layland K., Xie J., Angelis E., Wu K., Riemann I., Starcher B., MacLellan W.R., Hamm-Alvarez S.F. Increased degradation of extracellular matrix structures of lacrimal glands implicated in the pathogenesis of Sjögren's syndrome. Matrix Biol. 2008, 27:53-66.
36. Takaishi H., Kimura T., Dalal S., Okada Y., D'Armiento J. Joint diseases and matrix metalloproteinases: a role for MMP-13. Curr. Pharm. Biotechnol. 2008, 9(1):47-54.
37. Thompson H.A., Spooner B.S. Proteoglycan and glycosaminoglycan synthesis in embryonic mouse salivary glands: effects of beta-D-xyloside, an inhibitor of branching morphogenesis. J. Cell Biol. 1983, 96(5):1443-1450.
38. Tiedemann K., Bätge B., Müller P.K., Reinhardt D.P. Interactions of fibrillin-1 with heparin/heparan sulfate, implications for microfibrillar assembly. J. Biol. Chem. 2001, 38:36035-36042.
39. Tsubota K., Xu K., Fujihara T., Katagiri S., Takeuchi T. Decreased reflex tearing is associated with lymphocytic infiltration in lacrimal glands. J. Rheumatol. 1996, 23:313-320.
40. Xanthou G., Tapinos N.I., Polihronis M., Nezis I.P., Margaritis L.H., Moutsopoulos H.M. CD4 cytotoxic and dendritic cells in the immunopathologic lesion of Sjogren's syndrome. Clin. Exp. Immunol. 1999, 118:154-163.
41. Xue M., March L., Sambrook P.N., Jackson C.J. Differential regulation of matrix metalloproteinase 2 and matrix metalloproteinase 9 by activated protein C: relevance to inflammation in rheumatoid arthritis. Arthritis Rheum. 2007, 56(9):2864-2874.
42. Yamachika S., Nanni J.M., Nguyen K.H., Garces L., Lowry M.M., Robinson C.P., Brayer J., Oxford G.E., da Silveira A., Kerr M., Peck A.B. Excessive synthesis of matrix metalloproteinases in exocrine tissues of NOD mouse models for Sjogren's syndrome. J. Rheumatol. 1998, 25(12):2371-2380.
43. Yamachika S., Brayer J., Oxford G.E., Peck A.B., Humphreys-Beher M.G. Aberrant proteolytic digestion of biglycan and decorin by saliva and exocrine gland lysates from the NOD mouse model for autoimmune exocrinopathy. Clin. Exp. Rheumatol. 2000, 18(2):233-240.
44. Zoukhri D. Effect of inflammation on lacrimal gland function. Exp. Eye Res. 2006, 82(5):885-898.